Both in Biotechnology
Pluri vs Jasper Therapeutics
Over the past year PLUR returned −65.0% and JSPR returned −75.9%; their daily moves had a correlation of 0.06.
PLUR −65.0% JSPR −75.9%Growth of $1, one year, split-adjusted
| Metric | PLUR | JSPR |
|---|---|---|
| Price | $1.19 | $0.4692 |
| Market cap | $16.1M | $15.6M |
| Today | −3.26% | −8.20% |
| 1 month | +14.4% | −17.6% |
| 6 months | −64.4% | −48.3% |
| Year to date | −60.2% | −74.4% |
| 1 year | — | −74.1% |
| Revenue growth (YoY) | −15.8% | — |
| Gross margin | 58.5% | — |
| Net margin | −1755.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 15.8× | — |
| Net cash | -$23.9M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 80.2% | 75.9% |
| Short % of float | 0.3% | 22.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).